Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Sep 26, 2022; 10(27): 9828-9833
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9828
Figure 2
Figure 2 Histological and immunohistochemical findings of the esophageal carcinosarcoma. A: Histological mapping of the esophageal carcinosarcoma; B and C: Hematoxylin-eosin staining of the basal-like squamous cell carcinoma (BSC) component (red rectangle, B × 20, C × 100); D: β-catenin staining of the BSC component (positive, × 100); E: P53 staining of the BSC component (positive, × 100); F: Ki-67 staining of the BSC component (30%, × 100); G and H: Hematoxylin-eosin staining of the sarcoma component (orange arrow, G × 40, H × 400); I and J: Immunopositive carcinomatous cells for β-catenin are closely adjacent to the invasion depth (yellow circle, × 20, × 100); K: Ki-67 staining of the sarcoma component (30%, × 100); L: P53 staining of the sarcoma component (positive, × 100).